Evidence map›Paper›PMID 36076986›Full record

ArticleInternational journal of molecular sciences2022

Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients.

Daniel Martínez-Anaya, Dafné Moreno-Lorenzana, Adriana Reyes-León, Ulises Juárez-Figueroa, Michael Dean, María Montserrat Aguilar-Hernández, Netzi Rivera-Sánchez, Jessica García-Islas, Victoria Vieyra-Fuentes, Marta Zapata-Tarrés and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Editorial: Advancing Molecular Oncology in Mexico.International journal of molecular sciences · 2025
    Article
  6. Frontiers in oncology · 2025
    Article
  7. Article
  8. Frontiers in oncology · 2024
    Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Daniel Martínez-AnayaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.ORCID 0000-0002-8558-7984
Dafné Moreno-LorenzanaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.ORCID 0000-0003-3029-4241
Adriana Reyes-LeónLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Ulises Juárez-FigueroaLaboratorio de Citogenética, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.ORCID 0000-0001-8355-5818
Michael DeanLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA.ORCID 0000-0003-2234-0631
María Montserrat Aguilar-HernándezLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Netzi Rivera-SánchezLaboratorio de Genética Molecular, Hospital Infantil Teletón de Oncología, Queretaro 76140, Mexico.
Jessica García-IslasLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Victoria Vieyra-FuentesLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Marta Zapata-TarrésCoordinación de Investigación, Fundación IMSS, A.C., Mexico City 06600, Mexico.
Luis Juárez-VillegasServicio de Hemato-Oncología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Rogelio Paredes-AguileraServicio de Hematología, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Lourdes Vega-VegaDirección General, Hospital Infantil Teletón de Oncología, Queretaro 76140, Mexico.ORCID 0000-0002-1683-8356
Roberto Rivera-LunaServicio de Oncología, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
María Del Rocío Juárez-VelázquezLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.ORCID 0000-0002-2825-4729
Patricia Pérez-VeraLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.ORCID 0000-0001-5662-6991
Instituto Nacional de Pediatria · MXHospital Infantil de México Federico Gómez · MXMexican Social Security Institute · MXNational Cancer Institute · US

Funding

Consejo Nacional de Ciencia y Tecnología CONACyT (PDCPN-2014-01/248591 and Cátedra 2038Instituto Nacional de Pediatria Convocatoria recursos fiscales Instituto Nacional de Pediatría (INP 019/2016)
6 · The paper itself

Abstract

Ph-like subtypes with

Indexed as

Precursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaGene RearrangementHumansMexicoReceptors, CytokineSTAT5 Transcription FactorReceptors, CytokineSTAT5 Transcription FactorchildrenCRLF2 overexpressioniAMP21IGH::CRLF2MexicanP2RY8::CRLF2pCrklPh-likepre-B ALL

Identifiers

PMID36076986
PMCPMC9455471
OpenAlexW4292998567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.